Fukumoto Tetsuya, Sawada Takatora, Nishida Keigo, Onishi Tomoya, Watanabe Ryuta, Nishimura Kenichi, Miura Noriyoshi, Miyauchi Yuki, Kikugawa Tadahiko, Saika Takashi
Department of Urology, Ehime University Graduate School of Medicine, Toon 791-0295, Japan.
J Clin Med. 2025 Apr 24;14(9):2954. doi: 10.3390/jcm14092954.
HINOTORI™ is a robotic-assisted surgical platform developed in Japan. It has been applied in urologic procedures such as robot-assisted radical prostatectomy (RARP) and partial nephrectomy (RAPN). This study aimed to evaluate the clinical performance of HINOTORI™ compared with the da Vinci surgical system by analyzing outcomes of robot-assisted sacrocolpopexy (RSC) performed by a single skilled surgeon using a uniform surgical procedure. A total of 125 patients who underwent RSC for pelvic organ prolapse (POP) were analyzed. Surgical outcomes were compared between the HINOTORI™ (h-RSC group) and da Vinci (d-RSC group) platforms. Evaluated parameters included operative time, robotic console time, anterior compartment dissection time, suture time per stitch, perioperative complications, hospital stay, and POP recurrence. Operative and robotic console times were significantly longer in the h-RSC group (148 vs. 139 min, < 0.005; 109 vs. 95 min, < 0.001). Anterior compartment dissection time showed no significant difference ( = 0.58), but suture time per stitch was longer in the h-RSC group (76 vs. 60 s, < 0.005), possibly due to limited suture-cutting functionality, requiring manual assistance. No significant differences were observed in perioperative complications, hospital stay, and POP recurrence. HINOTORI™ demonstrated surgical precision and safety comparable to the da Vinci surgical system. It may serve as a viable alternative robotic platform, supporting broader adoption of robot-assisted surgical technologies.
HINOTORI™是一款在日本研发的机器人辅助手术平台。它已应用于泌尿外科手术，如机器人辅助根治性前列腺切除术（RARP）和部分肾切除术（RAPN）。本研究旨在通过分析由一名熟练外科医生采用统一手术流程进行的机器人辅助骶骨阴道固定术（RSC）的结果，评估HINOTORI™与达芬奇手术系统相比的临床性能。共分析了125例因盆腔器官脱垂（POP）接受RSC手术的患者。比较了HINOTORI™（h-RSC组）和达芬奇（d-RSC组）平台的手术结果。评估参数包括手术时间、机器人控制台操作时间、前间隙解剖时间、每针缝合时间、围手术期并发症、住院时间和POP复发情况。h-RSC组的手术时间和机器人控制台操作时间显著更长（148分钟对139分钟，<0.005；109分钟对95分钟，<0.001）。前间隙解剖时间无显著差异（=0.58），但h-RSC组每针缝合时间更长（76秒对60秒，<0.005），这可能是由于缝合切割功能有限，需要人工辅助。围手术期并发症、住院时间和POP复发情况未观察到显著差异。HINOTORI™显示出与达芬奇手术系统相当的手术精度和安全性。它可能成为一个可行的替代机器人平台，支持机器人辅助手术技术的更广泛应用。
